Author Correction: Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2.

Dong, Jianbo; Huang, Betty; Wang, Bo; Titong, Allison; Kankanamalage, Sachith Gallolu; Jia, Zhejun; Wright, Meredith; Parthasarathy, Pannaga; Liu, Yue

Dong, Jianbo; Huang, Betty; Wang, Bo; Titong, Allison; Kankanamalage, Sachith Gallolu; Jia, Zhejun; Wright, Meredith; Parthasarathy, Pannaga; Liu, Yue.

Dong J; Ab Studio Inc., Hayward, CA, USA. jianbo.dong@antibodystudio.com.
Huang B; Ab Studio Inc., Hayward, CA, USA.
Wang B; Ab Studio Inc., Hayward, CA, USA.
Titong A; Ab Studio Inc., Hayward, CA, USA.
Kankanamalage SG; Ab Studio Inc., Hayward, CA, USA.
Jia Z; Ab Studio Inc., Hayward, CA, USA.
Wright M; Ab Studio Inc., Hayward, CA, USA.
Parthasarathy P; Ab Studio Inc., Hayward, CA, USA.
Liu Y; Ab Studio Inc., Hayward, CA, USA.

Sci Rep ; 11(1): 4371, 2021 Feb 17.

Article in English | MEDLINE | ID: covidwho-1120740

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-82913-x

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google